Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.

Panidis D, Tziomalos K, Papadakis E, Vosnakis C, Chatzis P, Katsikis I.

Endocrine. 2013 Dec;44(3):583-90. doi: 10.1007/s12020-013-9971-5. Epub 2013 Apr 27. Review.

PMID:
23625194
2.

The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.

Panidis D, Tziomalos K, Papadakis E, Chatzis P, Kandaraki EA, Tsourdi EA, Katsikis I.

Clin Endocrinol (Oxf). 2014 Mar;80(3):432-8. doi: 10.1111/cen.12305. Epub 2013 Aug 28.

PMID:
23909452
3.

Dietary therapy in polycystic ovary syndrome.

Moran LJ, Brinkworth GD, Norman RJ.

Semin Reprod Med. 2008 Jan;26(1):85-92. doi: 10.1055/s-2007-992928. Review.

PMID:
18181086
4.

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.

Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.

Fertil Steril. 2008 Apr;89(4):899-906. Epub 2007 Nov 5.

PMID:
17980364
5.

Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome.

Legro RS, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Williams NI, Gnatuk CL, Estes SJ, Fleming J, Allison KC, Sarwer DB, Coutifaris C, Dokras A.

J Clin Endocrinol Metab. 2015 Nov;100(11):4048-58. doi: 10.1210/jc.2015-2778. Epub 2015 Sep 24.

6.

Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).

Vosnakis C, Georgopoulos NA, Rousso D, Mavromatidis G, Katsikis I, Roupas ND, Mamali I, Panidis D.

Gynecol Endocrinol. 2013 Mar;29(3):242-5. doi: 10.3109/09513590.2012.736557. Epub 2012 Nov 30.

PMID:
23194076
7.

Lifestyle changes in women with polycystic ovary syndrome.

Moran LJ, Hutchison SK, Norman RJ, Teede HJ.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD007506. doi: 10.1002/14651858.CD007506.pub3. Review.

PMID:
21735412
8.

The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.

Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.

J Clin Endocrinol Metab. 2008 Sep;93(9):3373-80. doi: 10.1210/jc.2008-0751. Epub 2008 Jun 26.

PMID:
18583464
9.

The role of obesity in the development of polycystic ovary syndrome.

Motta AB.

Curr Pharm Des. 2012;18(17):2482-91. Review.

PMID:
22376149
10.

The role of lifestyle modification in polycystic ovary syndrome.

Norman RJ, Davies MJ, Lord J, Moran LJ.

Trends Endocrinol Metab. 2002 Aug;13(6):251-7. Review.

PMID:
12128286
11.

Lifestyle changes in women with polycystic ovary syndrome.

Moran LJ, Hutchison SK, Norman RJ, Teede HJ.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007506. doi: 10.1002/14651858.CD007506.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD007506.

PMID:
21328294
12.

Cardiovascular risk in women with polycystic ovary syndrome.

Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C.

J Cardiovasc Med (Hagerstown). 2008 Oct;9(10):987-92. doi: 10.2459/JCM.0b013e32830b58d4. Review.

PMID:
18799960
13.

Cardiometabolic and reproductive benefits of early dietary energy restriction and voluntary exercise in an obese PCOS-prone rodent model.

Diane A, Kupreeva M, Borthwick F, Proctor SD, Pierce WD, Vine DF.

J Endocrinol. 2015 Sep;226(3):193-206. doi: 10.1530/JOE-14-0711. Epub 2015 Jul 17.

14.

Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss.

Ravn P, Haugen AG, Glintborg D.

Minerva Endocrinol. 2013 Mar;38(1):59-76. Review.

PMID:
23435443
15.

Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome.

Thomson RL, Buckley JD, Lim SS, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.

Fertil Steril. 2010 Oct;94(5):1812-6. doi: 10.1016/j.fertnstert.2009.11.001. Epub 2009 Dec 11.

PMID:
20004371
16.

Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.

Koiou E, Tziomalos K, Katsikis I, Kandaraki EA, Kalaitzakis E, Delkos D, Vosnakis C, Panidis D.

Gynecol Endocrinol. 2012 Jan;28(1):20-4. doi: 10.3109/09513590.2011.588745. Epub 2011 Jul 14.

PMID:
21756081
17.

Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.

Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ.

Fertil Steril. 2009 Dec;92(6):1966-82. doi: 10.1016/j.fertnstert.2008.09.018. Epub 2008 Dec 4.

PMID:
19062007
18.

Role of lifestyle modification in the management of polycystic ovary syndrome.

Hoeger KM.

Best Pract Res Clin Endocrinol Metab. 2006 Jun;20(2):293-310. Review.

PMID:
16772159
19.

Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.

Nybacka Å, Carlström K, Ståhle A, Nyrén S, Hellström PM, Hirschberg AL.

Fertil Steril. 2011 Dec;96(6):1508-13. doi: 10.1016/j.fertnstert.2011.09.006. Epub 2011 Sep 29.

PMID:
21962963
20.

Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena.

Rondanelli M, Perna S, Faliva M, Monteferrario F, Repaci E, Allieri F.

Arch Gynecol Obstet. 2014 Dec;290(6):1079-92. doi: 10.1007/s00404-014-3433-z. Epub 2014 Sep 9. Review.

PMID:
25200687

Supplemental Content

Support Center